MCKAYLA EBERHARDT: Open Payments
NPI 1457073124 · NORTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 27 payments from 10 companies in 2025. Trend: 2023 $370 · 2024 $496 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $121 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| ABBVIE INC. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Organon LLC | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Astellas Pharma US Inc | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: JARDIANCE, VOQUEZNA, MOUNJARO, TRELEGY ELLIPTA, Auvelity, NEXPLANON, REPATHA, XIFAXAN.
Industry payments across OH — which companies pay providers there.
